Did not become law. It stopped in the Senate's Health Care Committee on July 7, 2017. The 2017 session has ended.
2017 Regular Session
Senate Bill 793
Requires prescription drug manufacturer to report to Department of Consumer and Business Services prices and increases in prices of manufacturer's prescription drugs sold in Oregon.
What it does
The synopsis the Legislative Assembly published with the bill.
Requires prescription drug manufacturer to report to Department of Consumer and Business Services prices and increases in prices of manufacturer's prescription drugs sold in Oregon. Requires manufacturer to provide justification for increase in price greater than 3.4 percent for prescription drugs sold in Oregon longer than 36 months. Requires department to order manufacturer to refund excessive price increases to purchasers of prescription drugs. Declares emergency, effective on passage.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
February 14 to July 7, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action5 actions on 4 days
In the SenateFeb 14 to Jul 7 · stopped143 days
Waiting for a committeeFeb 14 to Feb 140 days
Health CareFeb 14 to Jul 7 · stopped143 days
Text
Each version as the Legislative Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.
In the Senate Feb 14 – Jul 7
- Feb 14Introduced
- Sent to Health Care
- Mar 9Heard in Health Care
- Apr 13Heard in Health Care
- Jul 7Died when the session ended
All 5 actions, as published
- Feb 14Introduction and first reading. Referred to President's desk.Senate
- Feb 14Referred to Health Care.Senate
- Mar 9Public Hearing held.Senate
- Apr 13Work Session held.Senate
- Jul 7In committee upon adjournment.Senate